HomeZVSA • NASDAQ
add
Zyversa Therapeutics Inc
Previous close
$0.77
Day range
$0.68 - $1.19
Year range
$0.55 - $7.30
Market cap
2.18M USD
Avg Volume
4.38M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.29M | -27.57% |
Net income | -1.42M | 89.34% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.29M | 27.46% |
Effective tax rate | 0.21% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.53M | -51.21% |
Total assets | 20.60M | -6.85% |
Total liabilities | 12.08M | 9.45% |
Total equity | 8.52M | — |
Shares outstanding | 2.57M | — |
Price to book | 0.23 | — |
Return on assets | -16.07% | — |
Return on capital | -41.39% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.42M | 89.34% |
Cash from operations | -1.22M | 56.07% |
Cash from investing | — | — |
Cash from financing | 2.63M | -39.43% |
Net change in cash | 1.41M | -9.68% |
Free cash flow | -965.66K | 56.16% |
About
Founded
2014
Headquarters
Website
Employees
7
